Pediatric Oncology Safety Simulation (223-2)

4:35 pm – 4:55 pm Friday, September 16

Pediatric Oncology patients are at high risk for rapid deterioration given their severity of illness, toxicity of interventions and associated immunosuppression. Pediatric Oncology focused escalation of care for patients experiencing clinical deterioration continues to present significant challenges within healthcare. At the current institution a two-year review of inpatient and outpatient oncologic emergencies was evaluated, and a comprehensive Oncology Safety Simulation Program was developed.The Oncology Safety Simulation Program has offered a hands on multi-disciplinary approach to educating physicians, nurse practitioners, nurses and pharmacists on safe practices during Oncology medical emergencies. Outcome data has been tracked to evaluate attendees' satisfaction and attendees' evaluation of their ability to utilize the education to change practices at the bedside. Data has been tracked with regards to use of intramuscular epinephrine administration during anaphylaxis and time to implementing the sepsis protocol during a sepsis workup. The simulation process development timeline will be reviewed, outcome data will be shared and latent safety effects will be reviewed.